-
Shares Of Catabasis Pharmaceuticals See-Saw Following Results Of Duchenne Muscular Dystrophy Study
Monday, January 25, 2016 - 2:15pm | 218Shares of Catabasis Pharmaceuticals Inc (NASDAQ: CATB), a clinical-stage small-cap biopharmaceutical company, were highly volatile during Monday's trading session after the company